Restricted accessResearch articleFirst published online 2022-09
Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial
Comorbid post-traumatic stress disorder and substance use disorder (PTSD-SUD) among women receiving substance use treatment are common. Few evidence-based interventions target PTSD-SUD, however, fewer are gender responsive. Mindfulness-based relapse prevention (MBRP) has shown effectiveness for women with SUD, although it does not explicitly target PTSD. Integration of trauma-focused and gender-responsive treatments into MBRP may address the limited availability of PTSD-SUD interventions for women. This study assessed feasibility and acceptability of trauma-integrated MBRP (TI-MBRP).
Methods:
A single-blind computer-generated cluster-randomized design was employed in which women with PTSD-SUD (N = 83) received either TI-MBRP (k = 5) or MBRP (k = 5). Measures of PTSD symptom severity and craving were administered at pre-, post-, 1-, 3-, 6-, 9-, and 12-month follow-up and assessed at the individual level.
Results:
TI-MBRP demonstrated acceptability among participants; however, attrition was high (64%) at 12-month follow-up. Reductions in PTSD were greater in the MBRP than in the TI-MBRP group at postcourse and 1-month follow-up, and there were significant reductions in PTSD severity and craving over the 12-month period in both conditions.
Conclusions:
Integrating trauma- and gender-focused interventions into MBRP was feasible and acceptable. MBRP alone may be effective in reducing both PTSD and SUD symptoms in women with PTSD-SUD; however, confirmatory studies are warranted.
Clinical Trial Registration Number:
NCT03505749.
Get full access to this article
View all access options for this article.
References
1.
CohenLR, HienDA. Treatment outcomes for women with substance abuse and PTSD who have experienced complex trauma. Psychiatr Serv, 2006; 57:100–106.
2.
Lev-RanS, Le StratY, ImtiazS, et al.Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: Results from a large representative sample. Am J Addict, 2013; 22:7–13.
3.
LansfordJE, DodgeKA, PettitGS, BatesJE. Does physical abuse in early childhood predict substance use in adolescence and early adulthood?. Child Maltreat, 2010; 15:190–194.
4.
CapaldiDM, KnobleNB, ShorttJW, KimHK. A systematic review of risk factors for intimate partner violence. Partner Abuse, 2012; 3:231–280.
5.
KhouryL, TangYL, BradleyB, et al.Substance use, childhood traumatic experience, and posttraumatic stress disorder in an urban civilian population. Depress Anxiety, 2010; 27:1077–1086.
6.
TorchallaI, NosenE. Sex and gender differences inPTSD and substance use disorder comorbidity. In: VujanovicVV, BackSE, eds. Posttraumatic Stress and Substance Use Disorders: A Comprehensive Clinical Handbook. New York, NY: Routledge, 2019:1623.
7.
GreenfieldSF, BackSE, LawsonK, BradyKT. Substance abuse in women. Psychiatr Clin North Am, 2010; 33:339–355.
8.
NajtP, Fusar-PoliP, BrambillaP. Co-occurring mental and substance abuse disorders: A review on the potential predictors and clinical outcomes. Psychiatr Res, 2011; 186:159–164.
9.
DifedeJ, OldenM, CukorJ. Evidence-based treatment of post-traumatic stress disorder. Annu Rev Med, 2014; 65:319–332.
10.
KaysenD, SimpsonT, DillworthT, et al.Alcohol problems and posttraumatic stress disorder in female crime victims. J Trauma Stress, 2006; 19:399–403.
11.
SimpsonTL. Childhood sexual abuse, PTSD, and the functional roles of alcohol use among women drinkers. Subst Use Misuse, 2003; 38:249–270.
12.
McCauleyJL, KilleenT, GrosDF, et al.Posttraumatic stress disorder and co-occurring substance use disorders: Advances in assessment and treatment. Clin Psychol (New York), 2012; 19:1–43.
13.
SchummJA, GoreWL. Simultaneous treatment of co-occurring posttraumatic stress disorder and substance use disorder. Curr Treat Options Psychiatry, 2016; 3:28–36.
14.
KilleenTK, BackSE, BradyKT. Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs. Drug Alcohol Rev, 2015; 34:234–241.
15.
OuimetteP, BrownPJ, OuimetteP, BrownPJ. Trauma and Substance Abuse: Causes, Consequences, and Treatment of Comorbid Disorders, 1st ed. Washington, DC: American Psychological Association, 2003.
16.
LancasterCL, GrosDF, MullarkeyMC, et al.Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders?. Behav Cogn Psychother, 2020; 48:38–53.
17.
MillsKL, TeessonM, BackSE, et al.Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: A randomized controlled trial. JAMA, 2012; 308:690–699.
18.
NajavitsLM, HienD. Helping vulnerable populations: A comprehensive review of the treatment outcome literature on substance use disorder and PTSD. J Clin Psychol, 2013; 69:433–479.
19.
FlanaganJC, KorteKJ, KilleenTK, BackSE. Concurrent treatment of substance use and PTSD. Curr Psychiatry Rep, 2016; 18:70.
20.
WalkerSC, MunoA, Sullivan-ColglazierC. Principles in practice: A multistate study of gender-responsive reforms in the juvenile justice system. Crime Delinq, 2015; 61:742–766.
21.
MessinaN, CalhounS, BraithwaiteJ. Trauma-informed treatment decreases PTSD among women offenders. J Trauma Dissociation, 2014; 15:6–23.
22.
SaxenaP, GrellaCE, MessinaNP. Continuing care and trauma in women offenders' substance use, psychiatric status, and self-efficacy outcomes. Women Crim Justice, 2016; 26:99–121.
23.
WattanapornKA, HoltfreterK. The impact of feminist pathways research on gender-responsive policy and practice. Fem Criminol, 2014; 9:191–207.
24.
BarringerA, BarringerA, HunterBA, et al.Empowerment and social support: Implications for practice and programming among minority women with substance abuse and criminal justice histories. J Behav Health Serv Res, 2017; 44:75–88.
GrellaCE. From generic to gender-responsive treatment: Changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoactive Drugs, 2008; 40(Suppl 5):327–343.
27.
SunA-P. Program factors related to women's substance abuse treatment retention and other outcomes: A review and critique. J Subst Abuse Treat, 2006; 30:1–20.
28.
AshleyOS, MarsdenME, BradyTM. Effectiveness of substance abuse treatment programming for women: A review. Am J Drug Alcohol Abuse, 2003; 29:19–53.
29.
ArnaudoCL, Andraka-ChristouB, AllgoodK. Psychiatric co-morbidities in pregnant women with opioid use disorders: Prevalence, impact, and implications for treatment. Curr Addict Rep, 2017; 4:1–13.
30.
StefanovicsEA, RosenheckRA. Comparing outcomes of women-only and mixed-gender intensive posttraumatic stress disorder treatment for female veterans. J Trauma Stress, 2019; 32:606–615.
31.
NajavitsL. Seeking Safety: A Treatment Manual for PTSD and Substance Abuse. New York, NY: Guilford Publications, 2002.
32.
ResickPA, SchnickeM. Cognitive Processing Therapy for Rape Victims: A Treatment Manual. Newbury Park, CA, Vol. 4: Sage, 1993.
33.
KoreckiJR, SchwebelFJ, VotawVR, WitkiewitzK. Mindfulness-based programs for substance use disorders: A systematic review of manualized treatments. Subst Abuse Treat Prev Policy, 2020; 15:1–37.
34.
BanksK, NewmanE, SaleemJ. An overview of the research on mindfulness-based interventions for treating symptoms of posttraumatic stress disorder: A systematic review. J Clin Psychol, 2015; 71:935–963.
35.
BoydJE, LaniusRA, McKinnonMC. Mindfulness-based treatments for posttraumatic stress disorder: A review of the treatment literature and neurobiological evidence. J Psychiatry Neurosci, 2018; 43:7–25.
36.
ChiesaA, AnselmiR, SerrettiA. Psychological mechanisms of mindfulness-based interventions: What do we know?. Holist Nurs Pract, 2014; 28:124–148.
37.
GuJ, StraussC, BondR, CavanaghK. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev, 2015; 37:1–12.
38.
PriddySE, HowardMO, HanleyAW, et al.Mindfulness meditation in the treatment of substance use disorders and preventing future relapse: Neurocognitive mechanisms and clinical implications. Subst Abuse Rehabil, 2018; 9:103.
39.
HeldP, OwensGP, ThomasEA, et al.A pilot study of brief self-compassion training with individuals in substance use disorder treatment. Traumatology, 2018; 24:219.
40.
EatonE, CaponeC, SheaMT, CameronA. Evaluation of self-compassion focused group treatment for co-occurring PTSD and substance use in veterans with posttraumatic guilt: A case study. Int J Group Psychother, 2020; 70:481–508.
41.
HeldP, OwensGP, AndersonSE. The interrelationships among trauma-related guilt and shame, disengagement coping, and PTSD in a sample of treatment-seeking substance users. Traumatology, 2015; 21:285.
42.
KatzD, TonerB. A systematic review of gender differences in the effectiveness of mindfulness-based treatments for substance use disorders. Mindfulness, 2013; 4:318–331.
43.
NajavitsLM, SullivanTP, SchmitzM, et al.Treatment utilization by women with PTSD and substance dependence. Am J Addict, 2004; 13:215–224.
44.
BowenS, ChawlaN, Alan MarlattG. Mindfulness-Based Relapse Prevention for Addictive Behaviors: A Clinician's Guide. New York, NY: Guilford Press, 2011.
45.
BowenS, WitkiewitzK, ClifasefiSL, et al.Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: A randomized clinical trial. JAMA Psychiatry, 2014; 71:547–556.
46.
BowenS, ChawlaN, CollinsSE, et al.Mindfulness-based relapse prevention for substance use disorders: A pilot efficacy trial. Subst Abuse, 2009; 30:295–305.
47.
WitkiewitzK, GreenfieldBL, BowenS. Mindfulness-based relapse prevention with racial and ethnic minority women. Addict Behav, 2013; 38:2821–2824.
48.
WitkiewitzK, WarnerK, SullyB, et al.Randomized trial comparing mindfulness-based relapse prevention with relapse prevention for women offenders at a residential addiction treatment center. Subst Use Misuse, 2014; 49:536–546.
49.
BlackDS, AmaroH. Moment-by-Moment in Women's Recovery (MMWR): Mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial. Behav Res Ther, 2019; 120:103437.
50.
FortunaLR, PorcheMV, PadillaA. A treatment development study of a cognitive and mindfulness-based therapy for adolescents with co-occurring post-traumatic stress and substance use disorder. Psychol Psychother, 2018; 91:42–62.
51.
NivN, HserY-I. Women-only and mixed-gender drug abuse treatment programs: Service needs, utilization and outcomes. Drug Alcohol Depend, 2007; 87:194–201.
52.
McKeeSA, HiltonNZ. Co-occurring substance use, PTSD, and IPV victimization: Implications for female offender services. Trauma Violence Abuse, 2019; 20:303–314.
53.
ResickPA, MonsonCM, ChardKM. Cognitive Processing Therapy for PTSD: A Comprehensive Manual. New York, NY: Guilford Publications, 2016.
54.
KimerlingR, TraftonJA, NguyenB. Validation of a brief screen for post-traumatic stress disorder with substance use disorder patients. Addict Behav, 2006; 31:2074–2079.
55.
FaulF, ErdfelderE, LangA-G, BuchnerA. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods, 2007; 39:175–191.
56.
DonnerA. Some aspects of the design and analysis of cluster randomization trials. J R Stat Soc Ser C Appl Stat, 1998; 47:95–113.
57.
CocksK, TorgersonDJ. Sample size calculations for pilot randomized trials: A confidence interval approach. J Clin Epidemiol, 2013; 66:197–201.
58.
TreeceEW, TreeceJWJ. Elements of research in nursing: Second edition. Nursing 2020, 1977; 7:12–13.
59.
BonevskiB, RandellM, PaulC, et al.Reaching the hard-to-reach: A systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol, 2014; 14:42.
60.
Ellard-GrayA, JeffreyNK, ChoubakM, CrannSE. Finding the hidden participant: Solutions for recruiting hidden, hard-to-reach, and vulnerable populations. Int J Qual Methods, 2015; 14:1–10.
61.
OrsmondGI, CohnES. The distinctive features of a feasibility study: Objectives and guiding questions. OTJR (Thorofare N J), 2015; 35:169–177.
62.
SekhonM, CartwrightM, FrancisJJ. Acceptability of healthcare interventions: An overview of reviews and development of a theoretical framework. BMC Health Serv Res, 2017; 17:88.
63.
FlanneryB, VolpicelliJ, PettinatiH. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res, 1999; 23:1289–1295.
64.
BlevinsCA, WeathersFW, DavisMT, et al.The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. J Trauma Stress, 2015; 28:489–498.
65.
MolenberghsG, VerbekeG. A review on linear mixed models for longitudinal data, possibly subject to dropout. Stat Model, 2001; 1:235–269.
66.
StahlerGJ, MennisJ, DuCetteJP. Residential and outpatient treatment completion for substance use disorders in the US: Moderation analysis by demographics and drug of choice. Addict Behav, 2016; 58:129–135.
67.
WickizerT, MaynardC, AtherlyA, et al.Completion rates of clients discharged from drug and alcohol treatment programs in Washington State. Am J Public Health, 1994; 84:215–221.
68.
Najavits. The problem of dropout from “gold standard” PTSD therapies. F1000Prime Rep, 2015; 7:43.
69.
GreenfieldSF, SugarmanDE, FreidCM, et al.Group therapy for women with substance use disorders: Results from the Women's Recovery Group Study. Drug Alcohol Depend, 2014; 142:245–253.
70.
DavisJP, BarrN, DworkinER, et al.Effect of mindfulness-based relapse prevention on impulsivity trajectories among young adults in residential substance use disorder treatment. Mindfulness, 2019; 10:1997–2009.
71.
HeldP, OwensGP, MonroeJR, ChardKM. Increased mindfulness skills as predictors of reduced trauma-related guilt in treatment-seeking veterans. J Trauma Stress, 2017; 30:425–431.
72.
ShoreyRC, ElmquistJ, GawrysiakMJ, et al.A randomized controlled trial of a mindfulness and acceptance group therapy for residential substance use patients. Subst Use Misuse, 2017; 52:1400–1410.
73.
SanchoM, De GraciaM, RodríguezRC, et al.Mindfulness-based interventions for the treatment of substance and behavioral addictions: A systematic review. Front Psychiatry, 2018; 9:95.
74.
LenzAS, HenesyR, CallenderK. Effectiveness of seeking safety for co-occurring posttraumatic stress disorder and substance use. J Couns Dev, 2016; 94:51–61.
75.
BowenS, SomohanoVC, RutkieRE, et al.Mindfulness-based relapse prevention for methadone maintenance: A feasibility trial. J Altern Complement Med, 2017; 23:541–544.
76.
KingAP, EricksonTM, GiardinoND, et al.A pilot study of group mindfulness-based cognitive therapy (MBCT) for combat veterans with posttraumatic stress disorder (PTSD). Depress Anxiety, 2013; 30:638–645.
77.
PolusnyMA, ErbesCR, ThurasP, et al.Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: A randomized clinical trial. JAMA, 2015; 314:456–465.
78.
StephensonKR, SimpsonTL, MartinezME, KearneyDJ. Changes in mindfulness and posttraumatic stress disorder symptoms among veterans enrolled in mindfulness-based stress reduction. J Clin Psychol, 2017; 73:201–217.
79.
EhlersA, SteilR. Maintenance of intrusive memories in posttraumatic stress disorder: A cognitive approach. Behav Cogn Psychother, 1995; 23:217–249.
80.
BowenS, De BoerD, BergmanAL. The role of mindfulness as approach-based coping in the PTSD-substance abuse cycle. Addict Behav, 2017; 64:212.
EhringT, FrankS, EhlersA. The role of rumination and reduced concreteness in the maintenance of posttraumatic stress disorder and depression following trauma. Cognit Ther Res, 2008; 32:488–506.
83.
MuthC, BalesKL, HindeK, et al.Alternative models for small samples in psychological research: Applying linear mixed effects models and generalized estimating equations to repeated measures data. Educ Psychol Meas, 2016; 76:64–87.
84.
KrumpalI. Determinants of social desirability bias in sensitive surveys: a literature review. Qual Quant, 2013; 47:2025–2047.
85.
GrohDR, FerrariJR, JasonLA. Self-reports of substance abusers: The impact of social desirability on social network variables. J Groups Addict Recover, 2009; 4:51–61.
86.
SomohanoVC, RehderKL, DingleT, et al.PTSD symptom clusters and craving differs by primary drug of choice. J Dual Diagn, 2019; 15:233–242.
87.
KredietE, BostoenT, BreeksemaJ, et al.Reviewing the potential of psychedelics for the treatment of PTSD. Int J Neuropsychopharmacol, 2020; 23:385–400.
88.
BakkerD, KazantzisN, RickwoodD, RickardN. Mental health smartphone apps: Review and evidence-based recommendations for future developments. JMIR Ment Health, 2016; 3:e7.
89.
PriesterMA, BrowneT, IachiniA, et al.Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review. J Subst Abuse Treat, 2016; 61:47–59.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
